Phospho-VEGF Receptor 2-Y1175 Rabbit mAb
FLK1; CD309; VEGFR; VEGFR2
Phospho-ErbB3/HER3-Y1289 Rabbit mAb
HER3; FERLK; LCCS2; VSCN1; ErbB-3; c-erbB3; erbB3-S; MDA-BF-1; c-erbB-3; p180-ErbB3; p45-sErbB3; p85-sErbB3
ABflo® 488 Rabbit anti-Human ErbB3/HER3 mAb (A22506)
Abclonal ABflo® 488 Rabbit anti-Human ErbB3/HER3 mAb (Catalog Number: A22506) encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases.
ABflo® 647 Rabbit anti-Human ErbB3/HER3 mAb (A22507)
Abclonal ABflo® 647 Rabbit anti-Human ErbB3/HER3 mAb (Catalog Number: A22507) encodes a member of the epidermal growth factor receptor (EGFR) family of receptor tyrosine kinases.
Anti-Lambda Light Chain Biotin(106651)
Caprico Biotechnologies Anti-Lambda Light Chain Biotin catalog number: 106651， The clone 528, a mouse monoclonal antibody, specifically reacts with an epitope of the ~170 kDa extracellular protein domain of human epidermal growth factor receptor or commonly...
BLU-9931
BLU-9931 (CAS No.: 1538604-68-0), a potent, highly selective, and irreversible fibroblast growth factor receptor 4 (FGFR4) inhibitor with an IC50 of 3 nM and a Kd of 6 nM. BLU-9931 has significant antitumor activity. >98%...
Nazartinib (EGF-816)
Nazartinib (EGF-816) (CAS No.: 1508250-71-2), a covalent mutant-selective EGFR inhibitor, with Ki and Kinact of 31 nM and 0.222 min-1 on EGFR(L858R/790M) mutant, respectively. >98% Purity. Synonyms: EGF-816, EGF816, EGFR inhibitor, epidermal growth factor receptor inhibitor For...
Pascolizumab Biosimilar, Anti-human IL-4 Antibody | C059P
The cheapest research grade pascolizumab biosimilar (anti-human anti-interleukin-4 (IL-4) monoclonal antibody, mAb) for ELISA, neutralization, in vivo functional assays such as bioanalytical PK and ADA assays, and those in vitro and in vivo assays for...
ALTIRATINIB (DCC-2701)
Background Information: Abstract (Ref 1): Altiratinib (DCC-2701) was designed based on the rationale of engineering a single therapeutic agent able to address multiple hallmarks of cancer. Specifically, Altiratinib inhibits not only mechanisms of tumor initiation and...